WINTON GROUP Ltd bought a new stake in shares of Quantum-Si incorporated (NASDAQ:QSI – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 34,610 shares of the company’s stock, valued at approximately $93,000.
Other hedge funds also recently modified their holdings of the company. Wolverine Asset Management LLC purchased a new stake in shares of Quantum-Si in the fourth quarter worth approximately $26,000. Abel Hall LLC purchased a new stake in Quantum-Si in the 4th quarter worth approximately $28,000. Dudley Capital Management LLC purchased a new stake in Quantum-Si in the 4th quarter worth approximately $30,000. XTX Topco Ltd boosted its stake in shares of Quantum-Si by 81.3% during the 3rd quarter. XTX Topco Ltd now owns 43,812 shares of the company’s stock valued at $39,000 after buying an additional 19,651 shares during the period. Finally, Bravias Capital Group LLC purchased a new position in shares of Quantum-Si during the 4th quarter valued at $55,000. Hedge funds and other institutional investors own 39.90% of the company’s stock.
Insiders Place Their Bets
In other news, CEO Jeffrey Alan Hawkins sold 23,707 shares of Quantum-Si stock in a transaction that occurred on Friday, March 21st. The shares were sold at an average price of $1.39, for a total value of $32,952.73. Following the transaction, the chief executive officer now owns 2,646,716 shares of the company’s stock, valued at $3,678,935.24. This trade represents a 0.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders sold 36,650 shares of company stock valued at $50,944 over the last quarter. Insiders own 30.04% of the company’s stock.
Quantum-Si Trading Down 5.5 %
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on QSI. National Bankshares set a $3.65 price objective on Quantum-Si in a research report on Wednesday, March 5th. Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a report on Wednesday, March 5th. Finally, HC Wainwright restated a “buy” rating and issued a $5.50 price objective on shares of Quantum-Si in a report on Tuesday, January 14th.
View Our Latest Analysis on Quantum-Si
Quantum-Si Company Profile
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Featured Stories
- Five stocks we like better than Quantum-Si
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Insider Buying Explained: What Investors Need to Know
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- What is the Dow Jones Industrial Average (DJIA)?
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding QSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quantum-Si incorporated (NASDAQ:QSI – Free Report).
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.